These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 28570007)
1. Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand the morphological spectrum of intraductal carcinoma. Shah RB; Yoon J; Liu G; Tian W Histopathology; 2017 Nov; 71(5):693-702. PubMed ID: 28570007 [TBL] [Abstract][Full Text] [Related]
2. Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate. Hickman RA; Yu H; Li J; Kong M; Shah RB; Zhou M; Melamed J; Deng FM Am J Surg Pathol; 2017 Apr; 41(4):550-556. PubMed ID: 28009609 [TBL] [Abstract][Full Text] [Related]
3. Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes. Shah RB; Nguyen JK; Przybycin CG; Reynolds JP; Cox R; Myles J; Klein E; McKenney JK Histopathology; 2019 Sep; 75(3):346-353. PubMed ID: 31012493 [TBL] [Abstract][Full Text] [Related]
4. ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia. Han B; Suleman K; Wang L; Siddiqui J; Sercia L; Magi-Galluzzi C; Palanisamy N; Chinnaiyan AM; Zhou M; Shah RB Am J Surg Pathol; 2010 Apr; 34(4):478-85. PubMed ID: 20220513 [TBL] [Abstract][Full Text] [Related]
5. Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies. Shah RB; Magi-Galluzzi C; Han B; Zhou M Am J Surg Pathol; 2010 Apr; 34(4):470-7. PubMed ID: 20182345 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion. Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY Hum Pathol; 2014 Aug; 45(8):1572-81. PubMed ID: 24842280 [TBL] [Abstract][Full Text] [Related]
7. Atypical cribriform lesions of the prostate: clinical significance, differential diagnosis and current concept of intraductal carcinoma of the prostate. Shah RB; Zhou M Adv Anat Pathol; 2012 Jul; 19(4):270-8. PubMed ID: 22692290 [TBL] [Abstract][Full Text] [Related]
8. Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance. Guo CC; Epstein JI Mod Pathol; 2006 Dec; 19(12):1528-35. PubMed ID: 16980940 [TBL] [Abstract][Full Text] [Related]
9. The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer. Epstein JI; Amin MB; Fine SW; Algaba F; Aron M; Baydar DE; Beltran AL; Brimo F; Cheville JC; Colecchia M; Comperat E; da Cunha IW; Delprado W; DeMarzo AM; Giannico GA; Gordetsky JB; Guo CC; Hansel DE; Hirsch MS; Huang J; Humphrey PA; Jimenez RE; Khani F; Kong Q; Kryvenko ON; Kunju LP; Lal P; Latour M; Lotan T; Maclean F; Magi-Galluzzi C; Mehra R; Menon S; Miyamoto H; Montironi R; Netto GJ; Nguyen JK; Osunkoya AO; Parwani A; Robinson BD; Rubin MA; Shah RB; So JS; Takahashi H; Tavora F; Tretiakova MS; True L; Wobker SE; Yang XJ; Zhou M; Zynger DL; Trpkov K Arch Pathol Lab Med; 2021 Apr; 145(4):461-493. PubMed ID: 32589068 [TBL] [Abstract][Full Text] [Related]
10. High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma of the prostate. Zhou M Mod Pathol; 2018 Jan; 31(S1):S71-79. PubMed ID: 29297491 [TBL] [Abstract][Full Text] [Related]
11. Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations. Khani F; Wobker SE; Hicks JL; Robinson BD; Barbieri CE; De Marzo AM; Epstein JI; Pritchard CC; Lotan TL J Pathol; 2019 Sep; 249(1):79-89. PubMed ID: 30993692 [TBL] [Abstract][Full Text] [Related]
12. Intraductal Carcinoma of the Prostate Gland: Recent Advances. Divatia MK; Ro JY Yonsei Med J; 2016 Sep; 57(5):1054-62. PubMed ID: 27401634 [TBL] [Abstract][Full Text] [Related]
13. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization. Haffner MC; Weier C; Xu MM; Vaghasia A; Gürel B; Gümüşkaya B; Esopi DM; Fedor H; Tan HL; Kulac I; Hicks J; Isaacs WB; Lotan TL; Nelson WG; Yegnasubramanian S; De Marzo AM J Pathol; 2016 Jan; 238(1):31-41. PubMed ID: 26331372 [TBL] [Abstract][Full Text] [Related]
14. Intraductal Adenocarcinoma of the Prostate With Cribriform or Papillary Ductal Morphology: Rare Biopsy Cases Lacking Associated Invasive High-grade Carcinoma. Russell DH; Epstein JI Am J Surg Pathol; 2022 Feb; 46(2):233-240. PubMed ID: 34619708 [TBL] [Abstract][Full Text] [Related]
15. PTEN loss in prostatic adenocarcinoma correlates with specific adverse histologic features (intraductal carcinoma, cribriform Gleason pattern 4 and stromogenic carcinoma). Shah RB; Shore KT; Yoon J; Mendrinos S; McKenney JK; Tian W Prostate; 2019 Aug; 79(11):1267-1273. PubMed ID: 31111513 [TBL] [Abstract][Full Text] [Related]
16. Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy. Morais CL; Han JS; Gordetsky J; Nagar MS; Anderson AE; Lee S; Hicks JL; Zhou M; Magi-Galluzzi C; Shah RB; Epstein JI; De Marzo AM; Lotan TL Am J Surg Pathol; 2015 Feb; 39(2):169-78. PubMed ID: 25517949 [TBL] [Abstract][Full Text] [Related]
17. Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: a prospective cohort study. Watts K; Li J; Magi-Galluzzi C; Zhou M Histopathology; 2013 Oct; 63(4):574-9. PubMed ID: 23931616 [TBL] [Abstract][Full Text] [Related]
18. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists. Iczkowski KA; Egevad L; Ma J; Harding-Jackson N; Algaba F; Billis A; Camparo P; Cheng L; Clouston D; Comperat EM; Datta MW; Evans AG; Griffiths DF; Guo CC; Hailemariam S; Huang W; Humphrey PA; Jiang Z; Kahane H; Kristiansen G; La Rosa FG; Lopez-Beltran A; MacLennan GT; Magi-Galluzzi C; Merrimen J; Montironi R; Osunkoya AO; Picken MM; Rao N; Shah RB; Shanks JH; Shen SS; Tawfik OW; True LD; Van der Kwast T; Varma M; Wheeler TM; Zynger DL; Sahr N; Bostwick DG Ann Diagn Pathol; 2014 Dec; 18(6):333-42. PubMed ID: 25263387 [TBL] [Abstract][Full Text] [Related]
19. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists. Gandhi JS; Smith SC; Paner GP; McKenney JK; Sekhri R; Osunkoya AO; Baras AS; DeMarzo AM; Cheville JC; Jimenez RE; Trpkov K; Colecchia M; Ro JY; Montironi R; Menon S; Hes O; Williamson SR; Hirsch MS; Netto GJ; Fine SW; Sirohi D; Kaushal S; Sangoi A; Robinson BD; Kweldam CF; Humphrey PA; Hansel DE; Schultz L; Magi-Galluzzi C; Przybycin CG; Shah RB; Mehra R; Kunju LP; Aron M; Kryvenko ON; Kench JG; Kuroda N; Tavora F; van der Kwast T; Grignon DJ; Epstein JI; Reuter VE; Amin MB Am J Surg Pathol; 2020 May; 44(5):673-680. PubMed ID: 31876580 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling. Shah RB; Bentley J; Jeffery Z; DeMarzo AM Hum Pathol; 2015 May; 46(5):698-706. PubMed ID: 25724568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]